MDS
Showing NaN - NaN of 10
MDS, AML Trial in France (venetoclax + azacitidine +/- donor lymphocyte infusion)
Not yet recruiting
- MDS
- AML
- venetoclax + azacitidine +/- donor lymphocyte infusion
-
Amiens, France
- +13 more
Jul 21, 2022
MDS Trial in France (transplantation)
Active, not recruiting
- MDS
- transplantation
-
Amiens, France
- +36 more
Jul 4, 2022
MDS, MDS Trial in France (Luspatercept Injection [Reblozyl], Eprex)
Recruiting
- MDS
- Myelodysplastic Syndromes
- Luspatercept Injection [Reblozyl]
- Eprex
-
Amiens, France
- +30 more
May 19, 2022
MDS Trial in France (SGI-110 administration)
Completed
- MDS
- SGI-110 administration
-
Angers, France
- +26 more
Dec 5, 2018
MDS Trial in France (Azacitidine and LDE255)
Completed
- MDS
- Azacitidine and LDE255
-
Amiens, France
- +23 more
Dec 5, 2018
MDS Trial in Belgium, France (Deferasirox, Vitamin D and Azacitidine)
Unknown status
- MDS
- Deferasirox, Vitamin D and Azacitidine
-
Gent, Belgium
- +14 more
Jan 9, 2018
MDS, AML, ALL Trial in France (Clofarabine in combination with IV busulfan and ATG)
Completed
- MDS
- +3 more
- Clofarabine in combination with IV busulfan and ATG
-
Lyon, France
- +5 more
Jul 18, 2017